TEMPUS
PulseAugur coverage of TEMPUS — every cluster mentioning TEMPUS across labs, papers, and developer communities, ranked by signal.
- 2026-08-24 regulatory Tempus received FDA clearance for its AI product designed to detect signs of pulmonary hypertension from standard ECGs. source
-
AI could halve chip design time but won't replace engineers, says Cadence exec
Cadence executive Teng Jinqing believes AI can significantly accelerate chip design, potentially halving the time required for certain tasks by automating repetitive processes and improving engineer productivity. Howeve…
-
Tempus AI product for pulmonary hypertension detection gets FDA clearance
Tempus has received clearance from the United States Food and Drug Administration (FDA) for a new AI product. This product is designed to detect signs of pulmonary hypertension using standard electrocardiograms (ECGs). …
-
Steve Case: U.S. must broaden innovation beyond coastal hubs
Steve Case argues that America's entrepreneurial spirit, which historically fueled its economic success, is crucial for leading the next century of innovation. He notes that venture capital has become overly concentrate…
-
Tempus upgrades AI platform for oncology drug development
Tempus has launched an upgraded version of its Lens platform, enhancing its agentic AI capabilities for oncology drug development. This new iteration aims to accelerate the discovery and application of new treatments by…
-
Tempus framework offers scalable, resource-efficient GEMM for edge AI
Researchers have developed Tempus, a new framework designed to optimize General Matrix Multiplication (GEMM) for edge AI deployments on AMD Versal SoCs. Unlike existing spatial scaling methods that fail on resource-cons…